Allied Market Research published a report, titled, “Stroke Management Market By Type (Diagnostics, Therapeutics, and Software), By Application (Ischemic Stroke and Hemorrhagic Stroke): Global Opportunity Analysis and Industry Forecast, 2022-2032.” According to the report, stroke management industry was valued at $36.1 billion in 2022, and is anticipated to reach $74 billion by 2032, registering a CAGR of 7.4% from 2023 to 2033.
Request Sample of the Report on Stroke Management Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/661
Prime determinants of growth
Rise in stroke cases, technological advancement in stroke management solutions, and rise in stroke awareness drive the growth of the stroke management market. However, high cost of stroke diagnostics and treatment is hampering the market growth. On the contrary, the integration of artificial intelligence and machine learning for stroke diagnosis and monitoring is expected to offer remunerative opportunities for the expansion of the stroke management market during the forecast period.
Economic Downturn Analysis: Impact of Recession in 2023 on the Stroke Management Market
- In the economic recession, the stroke management market is driven by technological advancements in stroke management solutions, rise in prevalence of stroke, and rise in new product approvals.
- However, increased manufacturing and operating costs, and fluctuations and adverse movement in shipping costs impacted the stroke management market growth during the recession.
The diagnostic segment to maintain its leadership status throughout the forecast period
Based on type, the diagnostic segment held the highest market share in 2022, accounting for more than two-thirds of the stroke management market revenue, owing to increase in awareness and stroke diagnosis and technological advancement in diagnostic imaging. However, the software segment is expected to witness the fastest CAGR of 9.4% from 2023 to 2032, owing to development of new software and increase in the use of software platforms for continuous stroke management.
For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/661
The ischemic stroke segment to maintain its leadership status throughout the forecast period
Based on application, the ischemic stroke segment held the highest market share in 2022, accounting for four-fifths of the stroke management market revenue, owing to high prevalence of ischemic stroke as compared to hemorrhagic stroke. However, the hemorrhagic stroke segment is expected to witness the fastest CAGR of 7.9% from 2023 to 2032, owing to rise in the early detection of stroke and rise in the prevalence of hemorrhagic stroke.
North America to maintain its dominance by 2032
Based on region, North America held the highest market share in terms of revenue in 2022, accounting for more than two-fifths of the global stroke management market revenue, owing to high prevalence of stroke, presence of well-developed healthcare infrastructure, and strong presence of market key players. However, the Asia-Pacific region is expected to witness the fastest CAGR of 8.8% from 2023 to 2032, owing to development of the pharmaceutical and medical technology industry, rise in the geriatric population in this region, and the high adoption of new technologies.
Leading Market Players:
- Abbott Laboratories
- Boston Scientific Corporation
- Bristol-Myers Squibb Company
- Cardinal Health
- General Electric Company
- Medtronic
- Siemens AG
- Aidoc
- Brainomix
- VasSol Inc.
- Qure.ai
- Viz.ai, Inc.
- METHINKS
- B Braun SE
- iSchemaView, Inc.
- NeuraSignal, Inc.
- Deepnoid Co., Ltd.
- Heuron Co., Ltd.
- JLK
- Koninklijke Philips N.V.
- Merck & Co. Inc.
The report provides a detailed analysis of the key players in the stroke management market. These players have adopted strategies such as, product launch, acquisition, product approval, and partnership to increase their market share and maintain dominant shares in the different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
𝐎𝐮𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐘𝐨𝐮 𝐀𝐧𝐬𝐰𝐞𝐫 𝐭𝐨 𝐁𝐞𝐥𝐨𝐰 𝐌𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧:
• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?
𝐑𝐞𝐠𝐢𝐨𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:-
• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
[email protected]
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
